News & Perspective

Oct 03, 2008

Oct 03, 2008

Plant cancellation shows problems in flu vaccine business

(CIDRAP News) – A flu vaccine manufacturer's decision not to build a US facility has highlighted the perpetual mismatch between flu-shot supply and demand—and the reality that the mismatch may undermine plans for pandemic flu vaccines.

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Aug 16, 2007

Aug 16, 2007

Glaxo sells more H5N1 vaccine to US, launches trial

(CIDRAP News) – The British pharmaceutical company GlaxoSmithKline (GSK) recently announced another major order of prepandemic H5N1 influenza vaccine from the US Department of Health and Human Services (HHS), along with plans to launch a North American clinical trial of the vaccine.

Jun 27, 2005

Jun 27, 2005

Momentum builds for cell-culture flu vaccines

(CIDRAP News) – You've got to gather a lot of eggs to supply the world with influenza vaccine, but that might change before long.

Dec 07, 2004

Dec 07, 2004

HHS buys 1.2 million flu vaccine doses from abroad

(CIDRAP News) – The federal government is buying 1.2 million doses of flu vaccine made in Germany to augment the strained US supply, the Department of Health and Human Services (HHS) announced today.

Oct 28, 2004

Oct 28, 2004

Progress on flu vaccine supply announced

(CIDRAP News) – About 5 million additional doses of injectable flu vaccine have been identified that will hopefully be added to the US supply, according to an announcement made today by Department of Health and Human Services (HHS) Secretary Tommy Thompson. In addition, 300,000 doses are being redirected to high-risk individuals from stores originally planned for military personnel and federal employees.

Oct 15, 2004

Oct 15, 2004

None of Chiron's flu vaccine is safe, FDA says

(CIDRAP News) – Federal health officials today ruled out using any of Chiron Corporation's influenza vaccine in the United States this year, following the completion of inspections at the company's plant in Liverpool, England.

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»